Figure 1From: RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapyKaplan-Meier survival estimates for patients with NSCLC, based on RRM1 mRNA expression in PBMCs.Back to article page